Lv1
80 积分 2024-12-03 加入
EFFICACY AND SAFETY OF DUPILUMAB FOR COPD WITH TYPE 2 INFLAMMATION
3天前
求助中
Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease Patients: A 7-Year Population-based Cohort Study
4天前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
4天前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
4天前
已完结
EFFECTIVENESS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN CHINESE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN REAL-WORLD CLINICAL PRACTICE
16天前
已关闭
FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD
17天前
已完结
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in COPD: A Post-hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS)
18天前
已完结
EFFECTIVENESS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN CHINESE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN REAL-WORLD CLINICAL PRACTICE
18天前
已完结
Sacubitril valsartan in aged patients with heart failure and reduced ejection fraction: a safe and beneficial therapy
24天前
已完结
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction
25天前
已完结
皖公网安备34019202002308
